Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration

American Journal of Neuroradiology

Volumn 30, Issue 8, 2009, Pages 1482-1487

  Erbetta, Alessandra ^a   Mandelli, M L ^a,b   Savoiardo, M ^a   Grisoli, M ^a   Bizzi, A ^a   Soliveri, P ^a   Chiapparini, L ^a   Prioni, S ^a   Bruzzone, M G ^a   Girotti, F ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b POLITECNICO DI MILANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANISOTROPY; ARTICLE; BASAL GANGLION; BRAIN REGION; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; FEMALE; GLOBUS PALLIDUS; HUMAN; MALE; PROGRESSIVE SUPRANUCLEAR PALSY; SUPERIOR CEREBELLAR PEDUNCLE; THALAMUS; TISSUE INJURY; WHITE MATTER;

AGED; CEREBRAL CORTEX; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL PATHWAYS; NEURODEGENERATIVE DISEASES; SUPRANUCLEAR PALSY, PROGRESSIVE; THALAMUS;

EID: 70349222765     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1615     Document Type: Article

References (44)

1. Di Maria E, Tabaton M, Vigo T, et al. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol 2000;47:374-377 (Pubitemid 30141849)
2. Hattori M, Hashizume Y, Yoshida M, et al. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain. Acta Neuropathol 2003;106: 143-149 Epub 2003 May 2 (Pubitemid 36869249)
3. Arvanitakis Z, Wszolek ZK. Recent advances in the understanding of tau protein and movement disorders. Curr Opin Neurol 2001;14:491-497 (Pubitemid 32703542)
4. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy Steele-Richardson-Olszewski syndrome: report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9 (Pubitemid 26243849)
5. Kumar R, Bergeron C, Pollanen MS, et al. Cortical-basal ganglionic degeneration. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders. 3rd ed. Baltimore: Williams & Wilkins Press; 1998:297-316
6. Maher ER, Lees AJ. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome progressive supranuclear palsy. Neurology 1986;36:1005-1008
7. Soliveri P, Monza D, Paridi D, et al. Cognitive and magnetic resonance aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 1999;53:502-507 (Pubitemid 29382042)
8. Soliveri P, Monza D, Paridi D, et al. Neuropsychology follow-up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2000;69:313-318 (Pubitemid 30636234)
9. Litvan I, Phipps M, Pharr VL, et al. Randomized placebo controlled trial of donepezil in patients with progressive supranuclear palsy. Neurology 2001;57:467-473 (Pubitemid 32757595)
10. Cummings JL. Frontal-subcortical circuits in human behavior. Arch Neurol 1993;50:873-880
11. Schneider JA, Watts RL, Gearing M, et al. Corticobasal degeneration: neuropathological and clinical heterogeneity. Neurology 1997;48:959-969 (Pubitemid 27175623)
12. Savoiardo M, Strada L, Girotti F, et al.MRimaging in progressive supranuclear palsy and Shy-Drager syndrome. J Comput Assist Tomogr 1989;13:555-560 (Pubitemid 19183895)
13. Savoiardo M, Girotti F, Strada L, et al. Magnetic resonance imaging in progressive supranuclear palsy and in other parkinsonian disorders. J Neural Transm Suppl 1994;42:93-110 (Pubitemid 24212881)
14. Cordato NJ, Duggins AJ, Halliday GM, et al. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 2005;128:1259-1266 (Pubitemid 40826180)
15. Boxer AL, Geschwind MD, Belfor N, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 2006;63:81-86 (Pubitemid 43063865)
16. Basser PJ, Mattiello J, LeBihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 1994;103:247-254
17. Jiang H, van Zijl PC, Kim J, et al. DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed 2006;81:106-116 Epub 2006 Jan 18 (Pubitemid 43144442)
18. Wiegell MR, Tuch DS, Larsson HB, et al. Automatic segmentation of thalamic nuclei from diffusion tensor magnetic resonance imaging. Neuroimage 2003;19:391-401 (Pubitemid 39665689)
19. Niemann K, Mennicken VR, Jeanmonod D, et al. The Morel stereotactic atlas of thehumanthalamus: atlas-to-MR registration of internally consistent canonical model. NeuroImage 2000;12:601-616
20. Picard N, Strick PL. Motor areas of the medial wall: a review of their location and functional activation. Cereb Cortex 1996;6:342-353 (Pubitemid 26161547)
21. Padovani A, Borroni B, Brambati SM, et al. Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2006;77:457-463
22. Paviour DC, Price SL, Stevens JM, et al. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2005;64:675-679
23. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-359
24. Lantos PL. The neuropathology of progressive supranuclear palsy. J Neural Transm Suppl 1994;42:137-152
25. Matsumoto R, Nakano I, Arai N, et al. Progressive supranuclear palsy with asymmetric lesions in the thalamus and cerebellum, with special reference to the unilateral predominance of many torpedoes. Acta Neuropathol 1996;92: 640-644 (Pubitemid 26401984)
26. Henderson JM, Carpenter K, Cartwright H, et al. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Brain 2000;123:1410-1421 (Pubitemid 30420941)
27. Seppi K, Schocke MF, Esterhammer R, et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 2003;60:922-927 (Pubitemid 36348922)
28. Hardman CD, Halliday GM. The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy. Mov Disord 1999;14:626-633 (Pubitemid 30011456)
29. DeVito JL, Anderson ME. An autoradiographics study of efferent connections of the globus pallidus in Macaca mulatta. Exp Brain Res 1982;46:107-117
30. Strick PL. Anatomical analysis of ventrolateral thalamic input to primate motor cortex. J Neurophysiol 1976;39:1020-1031
31. Schell GR, Strick PL. The origin of thalamic inputs to the arcuate premotor and supplementary motor area. J Neurosci 1984;4:539-560
32. Halliday GM, Macdonald V, Henderson JM. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. Brain 2005;128(pt 10):2272-2280 Epub 2005 Jul 13 (Pubitemid 41407967)
33. Nicoletti G, Lodi R, Condino F, et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 2006;129(pt 10):2679-2687 Epub 2006 Jun 30 (Pubitemid 44522101)
34. Soliveri P, Piacentini S, Girotti F. Limb apraxia and cognitive impairment in progressive supranuclear palsy. Neurocase 2005;11:263-267 (Pubitemid 41179596)
35. Tsuboi Y, Slowinski J, Joseph KA, et al. Atrophy of the superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2003;60:1766-1769 (Pubitemid 36737071)
36. Dickson DW, Bergeron C, Chin SS, et al. Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61:935-946 (Pubitemid 35278715)
37. Rebeiz JJ, Kolodny EH, Richardson EP. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18:20-33
38. Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112:1171-1192
39. Savoiardo M, Grisoli M, Girotti F. Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementia. Adv Neurol 2000;82:197-208
40. Josephs KA, Whitwell JL, Dickson DW, et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 2008;29:280-289
41. Brooks DJ. Functional imaging studies in corticobasal degeneration. Adv Neurol 2000;82:209-215
42. Borroni B, Garibotto V, Agosti C, et al. White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. Arch Neurol 2008;65:796-801 (Pubitemid 351831458)
43. Rizzo G, Martinelli P, Manners D, et al. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain 2008;131:2690-2700
44. Wedeen VJ, Wang RP, Schmahmann JD, et al. Diffusion spectrum magnetic resonance imaging (DSI) tractography of crossing fibers. Neuroimage 2008;41: 1267-1277